Apollomics COO Chen Yi-Kuei files Form 3 holdings
Apollomics Inc. director and COO Chen Yi-Kuei filed an initial Form 3 reporting his equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Apollomics Inc. director and COO Chen Yi-Kuei filed an initial Form 3 reporting his equity holdings. He directly holds restricted stock units covering 20,000 Class A Ordinary Shares, vesting in four installments of 5,000 shares each during 2026. Each unit represents the right to receive one share. Through Maxpro Investment Co., Ltd., he is attributed 101,248 Class A Ordinary Shares and warrants exercisable for 3,823 Class A Ordinary Shares at an adjusted exercise price of $1,150.00 per full share, or $11.50 per warrant. He disclaims beneficial ownership of the Maxpro-held securities except to the extent of his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
Footnotes (4)
- F1. The reporting person is member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. The reporting person disclaims beneficial ownership of theses securities except to the extent of his pecuniary interest therein.
- F2. The restricted stock units were vested with respect to 5,000 shares on February 17, 2026, with an additional 5,000 shares vesting on each of May 17, 2026, August 17, 2026 and November 17, 2026.
- F3. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.
- F4. Reflects the adjusted exercise price of $1,150.00 per full share, as each warrant is exercisable for 0.01 Class A Ordinary Share at a price of $11.50 per warrant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Apollomics (APLM) COO Chen Yi-Kuei report on this Form 3?
How many Apollomics (APLM) RSUs does Chen Yi-Kuei hold and how do they vest?
What are the terms of the Apollomics (APLM) warrants held indirectly via Maxpro?
Does this Apollomics (APLM) Form 3 show insider buying or selling by Chen Yi-Kuei?
AI-generated analysis. How Rhea-AI works. Not financial advice.